Wednesday, 19 July 2017

GlaxoSmithKline to axe 320 UK jobs in manufacturing shake-up



GlaxoSmithKline is to axe more than 300 jobs, abandon plans to build a new site in Cumbria and sell off its Horlicks brand in the UK.
 
The FTSE 100 giant has announced a reorganisation of its manufacturing network in Britain which will include the closure of the plant in Slough where Horlicks is made.


Sales of the malted milk drink in the UK are dwarfed by the brand's revenues in India and south east Asia, where Glaxo will retain control of the business.


Glaxo is also selling its sports supplement brand Maxi Nutrition in the UK - confirming a move first reported by Sky News.


The two brands' combined sales in Britain amount to around £30m a year.


Glaxo's proposals also include the outsourcing of some jobs at a separate drug-making plant in Worthing, West Sussex.





SKY     News.